UnitedHealth Group Incorporated $UNH Stock Holdings Lowered by Groupe la Francaise

Groupe la Francaise reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 4.4% during the 1st quarter, HoldingsChannel.com reports. The fund owned 28,198 shares of the healthcare conglomerate’s stock after selling 1,285 shares during the quarter. Groupe la Francaise’s holdings in UnitedHealth Group were worth $14,528,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in UNH. Marshall & Sterling Wealth Advisors Inc. purchased a new position in shares of UnitedHealth Group in the fourth quarter worth approximately $26,000. Bayforest Capital Ltd increased its position in shares of UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd increased its position in shares of UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 50 shares in the last quarter. Kapitalo Investimentos Ltda purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $41,000. Finally, Copia Wealth Management purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $42,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares of the company’s stock, valued at $3,171,390. This represents a 5.36% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.28% of the stock is currently owned by corporate insiders.

UnitedHealth Group Trading Up 1.2%

Shares of UnitedHealth Group stock opened at $307.0980 on Friday. The stock has a market capitalization of $278.13 billion, a P/E ratio of 13.31, a price-to-earnings-growth ratio of 1.96 and a beta of 0.43. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a 50-day simple moving average of $288.39 and a 200 day simple moving average of $389.57. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the prior year, the company earned $6.80 EPS. The firm’s revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.9%. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

Analysts Set New Price Targets

Several research firms have commented on UNH. Piper Sandler decreased their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. KeyCorp decreased their target price on shares of UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. HSBC reissued a “reduce” rating and issued a $270.00 target price (down from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Raymond James Financial downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, May 14th. Finally, Wolfe Research reduced their price objective on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a research note on Tuesday, May 20th. Fifteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $365.38.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.